Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohort
PAC was used more conservatively than guidelines suggest and was mainly driven by hypoalbuminaemia severity in both adults and children. Although not included in the guidelines practice points, DOACs were used as often as coumarins in adults.
Authors
- Bryce A. Kerlin (ORCID: https://orcid.org/0000-0002-1756-8271)
- David Massicotte‐Azarniouch (ORCID: https://orcid.org/0000-0002-6954-2030)
- Michelle Hladunewich
- Amy K. Mottl (ORCID: https://orcid.org/0000-0002-4258-1726)
- Benjamin Wooden (ORCID: https://orcid.org/0000-0003-4286-5005)
- Pietro A. Canetta (ORCID: https://orcid.org/0000-0003-1130-5486)
- Michelle N. Rheault (ORCID: https://orcid.org/0000-0003-2494-3970)
- Gaia Coppock
- Andrew S. Bomback (ORCID: https://orcid.org/0000-0001-5449-1667)
- Mariela Navarro-Torres
- Blanca Tarragón (ORCID: https://orcid.org/0000-0003-1784-6929)
- Heedeok Han
- Vimal K. Derebail (ORCID: https://orcid.org/0000-0002-7662-7497)
- Dorey A. Glenn (ORCID: https://orcid.org/0000-0003-2796-3037)
- Laura Mariani (ORCID: https://orcid.org/0000-0002-4305-9884)
Institutions
- University of North Carolina at Chapel Hill (US)
- Nationwide Children's Hospital (US)
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- University of Michigan (US)
- Columbia University Irving Medical Center (US)
- Health Sciences Centre (CA)
- Michigan Medicine (US)
- University of Minnesota Children's Hospital (US)
- The Ohio State University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1093/ckj/sfaf104
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundación Alfonso Martín Escudero
- National Institute of Diabetes and Digestive and Kidney Diseases